www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Release
<< Back
Taro to Announce Second Quarter Results on November 8, 2016

Earnings Call to Discuss Results to be Conducted Wednesday, November 9 at 8:30 am ET

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Oct. 31, 2016-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2016, on Tuesday, November 8, 2016.

The Company will conduct an earnings call at 8:30 am ET on Wednesday, November 9, 2016, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:30 am ET on Wednesday, November 9, 2016)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

         
Event   Date and time  

Telephone number/ website

Earnings release   November 8, 2016  

www.taro.com

Earnings conference call   8:30 am ET

Wednesday,

November 9, 2016

 

Participant Toll-Free Dial-In Number: +1 (844) 421-0601

Participant International Dial-In Number: +1 (716) 247-5800

ID: 10641252

 

Via audio webcast, details of which will be made available on www.taro.com

Replay of conference call   November 9, 2016 to

November 25, 2016

 

+ 1 (855) 859-2056 or +1 (855) 537-3406

ID: 10641252

 

Via audio webcast playback, details of which will be made available on www.taro.com

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Taro Pharmaceutical Industries Ltd.
c/o Taro Pharmaceuticals U.S.A., Inc.
Three Skyline Drive
Hawthorne, New York 10532
(NYSE: TARO)

Source: Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.
Mariano Balaguer, 914-345-9001
VP, CFO & CAO
Mariano.Balaguer@Taro.com
or
William J. Coote, 914-345-9001
William.Coote@taro.com

Terms of Use
  |  
Privacy Statement
  |  
Safe Harbor Statement